Human FGF21 Assay Kit 27997

Catalogue Number: 27997-IBL

Manufacturer:IBL - (Immuno-Biologicals Laboratories Co Ltd)
Type:Human ELISA Kit
Shipping Condition:Blue Ice
Storage Condition:2-8°C
Unit(s): 96 well plate
Range: 31.3 ~ 2,000 pg/mL
Sensitivity:
Sample type: Cell Culture Supernatant, Plasma, Serum
Sample size:

Description

Description: FGF19 subfamily composed of FGF19, FGF21 and FGF23 binds the receptors, α/βKlotho and it is characterized as a factor group which has hormonal functions. The novel system consisted of α/βKlotho and FGF19 subfamily regulates integrally metabolism of minerals, lipids, energy and amino acids. This novel regulating system involves important homeostatic mechanism for biological body such asmetabolism of bile acid and cholesterol in the liver (FGF19), energy and glycolipids metabolism (FGF21) and phosphate, calcium and vitamin D metabolism in kidney (FGF23) in fasting state. FGF21 is secreted in the liver and it is reported that it has a lipolytic action in fatty tissues. FGF21 binds a receptor consisted of FGFR and βKlotho. FGF21 reacts in emptiness and it accelerates lipid metabolism in liver, Triacylglycerol (TG) is used as lipid acid and Ketone bodies are produced by the metabolism. As a result, it is used as an energy source. In this process, FGF21 is released and acts as a hormone-like factor. In relation to the concentration of FGF21 in blood, it is measured and reported that the correlation with many diseases like gestational diabetes mellitus, mitochondrial dysfunction in HIV infection, friedreich ataxia, coronary artery disease, carotid atherosclerosis, non-alcoholic fatty liver disease, rheumatoid arthritis, diabetic nephropathy, type2 diabetes, dyslipidemia and, obesity and metabolic syndrome. This kit can assay Human blood FGF21 density. The control set is available for sale on request.

Price
£591.00


Find out about delivery

SUPPORT

outstanding technical support

PRODUCT

we offer a full product guarantee

DELIVERY

we offer free delivery to UK universities and non profit organisations